![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1047, 2005-01, pp. : 14-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peginterferon-α-2a/ribavirin: First report of cataracts: case report
Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reactions Weekly, Vol. 1, Iss. 1049, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peginterferon-α-2b/ribavirin withdrawal: Ulcerative colitis: case report
Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peginterferon-α-2b/ribavirin: Ulcerative colitis: case report
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peginterferon-α-2a/ribavirin: Thyrotoxic periodic paralysis: case report
Reactions Weekly, Vol. 1, Iss. 1186, 2008-01 ,pp. :